Navigation Links
Drug Found To Bring Relief For Individuals With Early Parkinson’

According to researchers the drug selegiline, also known as Eldepryl, may be an effective treatment for patients with newly diagnosed Parkinson’s // disease.

Selegiline belongs to a group of drugs called monoamine oxidase type B inhibitors, which are used to slow the progression of Parkinson’s disease. Doctors have been slow to prescribe selegiline to patients because previous studies have linked it to an increased risk of death. However, selegiline did not increase the risk of death for patients in the current study.

Researchers analyzed 17 trials that compared MAOBIs to a placebo and the commonly prescribed Parkinson’s drug levodopa (Dopar or Larodopa). Results show MAOBIs, like selegiline, reduced disability and movement problems without posing significant side effects. Patients who took MAOBIs also required less levodopa than those on placebo. This is important because long-term use of levodopa is associated with negative side effects. Researchers say another benefit of MAOBIs is they are relatively inexpensive.

In conclusion researchers say, MAOBIs reduce disability, the need for levodopa, and the incidence of motor fluctuations without substantial side effects or increased mortality .However they say that large, long-term comparative trials that include patient-rated quality of life measures are needed.
'"/>




Page: 1

Related medicine news :

1. Fluoride Found Effective in Osteoporosis
2. Implantable Contact Lens Found Safe and Effective
3. Cancer hazard Found With Animal-Based Nutrients
4. Processed Meat, Diabetes connection Found
5. Night Time Aspirin Regimen Found to Reduce Blood Pressure
6. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
7. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
8. Preventive Therapies Found to be More Effective in Managing Migraines
9. Common Cold Found to Fight Cancer
10. Circumcision Found To Prevent HIV Spread
11. Drug Found To Reduce The Transmission Of Herpes
Post Your Comments:
(Date:8/29/2008)... CE Mark Opens Market to More Than 30 Europe...oana Medical, Inc. announced today,that it has suc...s for ISO,13485 and the Medical Device Directive (...he use of the coveted CE Mark -- or Conformite Eur...ce System. This expands Hoana,s,patient safety rea...
(Date:8/29/2008)... Allsup explains financial i...nning calculators available to people with disabil... (Vocus) August 29, 2008 -- Deciding how to move f... is a personal matter, but it,s important that ind...r financial options, according to http://www.alls...
(Date:8/28/2008)...- Revenues increase 138% versus Q2 2007 - Nin...ug. 28 /PRNewswire-FirstCall/ - CRH Medical Corpor...s for the three and six months,ended June 30, 2008...three,months ended June 30, 2008 increased 138% to...od in 2007. Revenue for the six months ended June,...
(Date:8/28/2008)...se is verbal, financial and physical, especially f..., Aug. 28 (HealthDay News) -- A new study says tha...nt from various forms of abuse. , The Universi...e verbal abuse (9 percent), being taken advantage ...0.2 percent). The team also found that seniors wit...
Breaking Medicine News(10 mins):Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 2Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 3Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 4Health News:Social Security Disability Can Be Key to Financial Future 2Health News:Social Security Disability Can Be Key to Financial Future 3Health News:Social Security Disability Can Be Key to Financial Future 4Health News:Social Security Disability Can Be Key to Financial Future 5Health News:Social Security Disability Can Be Key to Financial Future 6Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:13% of Seniors Report Being Mistreated 2
...stance is a major medical problem often leading to...ight greatly increases the odds someone will be in... people are afflicted. The insulin suppression t... however, it is too difficult to administer to lar...
...continue to be a major complication of diabetes, d...half of all amputations are currently performed am...changes in the tiny blood vessels in the retinas o...en diagnosed with the disease before age 30. All w...
...shows hydrotherapy, or water exercise, may improve...itis.// Researchers from Australia studied more th... than age 50. Patients were divided into three gro...es a week in a swimming pool, the second exercised...
..., Keith Black, M.D., from Cedars-Sinai Medical Cen...tive treatment for brain cancer. While his resear...r along the way.//Latest research involves an effe...ays brain tumors try to hide proteins on the tumor...
Other Medicine News:Health News:New vaccine for brain cancer 2
(Date:8/28/2008)... -- Intercell AG (VSE: ICLL) today,announced that ... Phase II,clinical trial of V710, an investigation...reus (S. aureus) infections. This randomized doubl... the safety and immunogenicity of,the vaccine cand...,hemodialysis. This trial start follows the initia...
(Date:8/27/2008)... centers involved in 10-year study, CHICAGO, Aug....r study,published in the August 28 issue of the Ne... sulfate administered to women delivering before 3...palsy by 50 percent. The,Beneficial Effects of Ant...d in 18 centers in the U.S., including Northwester...
(Date:8/27/2008)...-FirstCall/ --, - Oralair(R) Grasses 300IR Highly...udy Conducted in an Allergen Challenge Chamber, S...ults of a new study,conducted in an Allergen Chall...ses included 86 adult patients exposed to,grass po... 1 week, 1 month,2 and 4 months without a titrati...
(Date:8/26/2008)...The Oregon Tourism Commission,launched its new fre...ogram,(Q Care) this week on http://www.OregonQCar...ted to support the tourism and,hospitality industr...ing,the importance of quality customer service, th...ources to better serve Oregon,s visitors., "We,ve...
Breaking Medicine Technology:Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection 2Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection 3National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births 2National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births 3Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 2Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 3Oregon Tourism Commission Unveils New Online Customer Service Training Program 2Inhalant Abuse Prevention Program to Be Launched in Maryland Schools 2307 1September is National Pain Awareness Month 405 1September is National Pain Awareness Month 405 2September is National Pain Awareness Month 405 3September is National Pain Awareness Month 405 4Acute lung injury patients one third less likely to die in closed model ICUs 2302 1Acute lung injury patients one third less likely to die in closed model ICUs 2302 2Acute lung injury patients one third less likely to die in closed model ICUs 2302 3The impact of physical activity on weight bearing knee joint 2297 1The impact of physical activity on weight bearing knee joint 2297 2The impact of physical activity on weight bearing knee joint 2297 3
Lyphochek Benzo/TCA Control Set B is ideal for monitoring HPLC methods for identification and quantitation of benzodiazepines and antidepressant drugs.
Lyphochek Therapeutic Drug Monitoring Control (TDM) contains over 40 analytes with assayed values at three clinically significant levels.
Lyphochek Endocrine Control is a human based product designed to monitor plasma catecholamine testing procedures by HPLC. The analytes are spiked at critical concentrations to cover the dynamic range
Lyphochek Urine Metals Control incorporates two levels of critical trace elements, heavy metals and organic metabolites, and is ideal for environmental and industrial testing.
Medicine Products: